3/16
06:54 am
legn
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Low
Report
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
3/16
06:26 am
legn
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Low
Report
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
3/16
06:10 am
legn
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Low
Report
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
3/16
03:05 am
legn
Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]
Low
Report
Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]
3/13
06:18 am
legn
Legend Biotech (LEGN) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".
Low
Report
Legend Biotech (LEGN) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".
3/11
09:58 pm
legn
Legend Biotech Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Legend Biotech Q4 Earnings Call Highlights [Yahoo! Finance]
3/11
01:40 pm
legn
Legend Biotech (LEGN) had its price target lowered by Morgan Stanley from $50.00 to $49.00. They now have an "overweight" rating on the stock.
Low
Report
Legend Biotech (LEGN) had its price target lowered by Morgan Stanley from $50.00 to $49.00. They now have an "overweight" rating on the stock.
3/11
10:18 am
legn
Legend Biotech (LEGN) had its price target lowered by Royal Bank Of Canada from $66.00 to $62.00. They now have an "outperform" rating on the stock.
Low
Report
Legend Biotech (LEGN) had its price target lowered by Royal Bank Of Canada from $66.00 to $62.00. They now have an "outperform" rating on the stock.
Raymond James Financial, Inc.
Raymond James Financial, Inc.
3/18
07:05 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Heyman Tomas J.
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Heyman Tomas J.
3/18
07:03 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Meng Robin
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Meng Robin
3/18
07:01 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Salovey Peter
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Salovey Peter
3/18
07:00 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Casey Patrick John
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Casey Patrick John
3/18
06:58 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Kung Gareth
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Kung Gareth
3/18
06:57 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Mao Li
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Mao Li
3/18
06:56 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Ji Darren Xiaohui
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Ji Darren Xiaohui
3/18
06:54 pm
legn
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Zhang Fangliang
Low
Report
Form 3 Legend Biotech Corp For: Mar 18 Filed by: Zhang Fangliang
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register